Peregrine Capital Management LLC lessened its holdings in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN - Free Report) by 60.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 113,075 shares of the company's stock after selling 170,284 shares during the quarter. Peregrine Capital Management LLC owned about 0.18% of Guardian Pharmacy Services worth $2,291,000 at the end of the most recent quarter.
A number of other large investors have also recently modified their holdings of GRDN. Allspring Global Investments Holdings LLC bought a new stake in shares of Guardian Pharmacy Services during the 3rd quarter valued at about $5,460,000. Stephens Inc. AR bought a new stake in Guardian Pharmacy Services in the 3rd quarter worth approximately $189,000. Royce & Associates LP bought a new stake in Guardian Pharmacy Services in the 3rd quarter worth approximately $1,260,000. Foundry Partners LLC bought a new stake in Guardian Pharmacy Services in the 3rd quarter worth approximately $1,680,000. Finally, Maven Securities LTD bought a new stake in Guardian Pharmacy Services in the 3rd quarter worth approximately $3,033,000.
Guardian Pharmacy Services Price Performance
Guardian Pharmacy Services stock traded down $0.54 during trading hours on Friday, reaching $19.58. The company had a trading volume of 43,787 shares, compared to its average volume of 51,354. The stock has a 50-day simple moving average of $21.09. Guardian Pharmacy Services, Inc. has a 12-month low of $14.16 and a 12-month high of $25.74.
Wall Street Analysts Forecast Growth
Separately, Truist Financial boosted their target price on Guardian Pharmacy Services from $22.00 to $24.00 and gave the stock a "buy" rating in a research report on Friday, November 15th.
Check Out Our Latest Analysis on Guardian Pharmacy Services
About Guardian Pharmacy Services
(
Free Report)
Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.
Recommended Stories
Before you consider Guardian Pharmacy Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Guardian Pharmacy Services wasn't on the list.
While Guardian Pharmacy Services currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
